These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34676579)

  • 1. Use of real-world evidence in translational pharmacology research.
    Charvériat M; Darmoni SJ; Lafon V; Moore N; Bordet R; Veys J; Mouthon F;
    Fundam Clin Pharmacol; 2022 Apr; 36(2):230-236. PubMed ID: 34676579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Evidence-Current Developments and Perspectives.
    Schad F; Thronicke A
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Evidence: A Primer.
    Dang A
    Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational hurdles with cannabis medicines.
    Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceed with Caution When Using Real World Data and Real World Evidence.
    Kim HS; Kim JH
    J Korean Med Sci; 2019 Jan; 34(4):e28. PubMed ID: 30686950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.
    Franco JS; Vizcaya D
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00661. PubMed ID: 32965783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a better understanding about real-world evidence.
    Liu M; Qi Y; Wang W; Sun X
    Eur J Hosp Pharm; 2022 Jan; 29(1):8-11. PubMed ID: 34857642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoepidemiology.
    Moore N; Blin P; Droz C
    Handb Exp Pharmacol; 2019; 260():433-451. PubMed ID: 31768750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?
    Simon GE; Platt R; Watanabe JH; Bindman AB; John London A; Horberg M; Hernandez A; Califf RM
    Clin Pharmacol Ther; 2022 Jan; 111(1):30-34. PubMed ID: 33895994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
    Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing the utilization of real-world data and real-world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop.
    Liu J; Rowland-Yeo K; Winterstein A; Dagenais S; Liu Q; Barrett JS; Zhu R; Ghobadi C; Datta-Mannan A; Hsu J; Menon S; Ahmed M; Manchandani P; Ravenstijn P
    Clin Transl Sci; 2024 Apr; 17(4):e13785. PubMed ID: 38572980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.
    Kim HS; Lee S; Kim JH
    J Korean Med Sci; 2018 Aug; 33(34):e213. PubMed ID: 30127705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From real world data to real world evidence to improve outcomes in neuro-ophthalmology.
    Colman BD; Zhu Z; Qi Z; van der Walt A
    Eye (Lond); 2024 Aug; 38(12):2448-2456. PubMed ID: 38844583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
    Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
    Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world evidence: An Indian perspective.
    Dang A; Vallish BN
    Perspect Clin Res; 2016; 7(4):156-160. PubMed ID: 27843789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real World Evidence in Medical Cannabis Research.
    Banerjee R; Erridge S; Salazar O; Mangal N; Couch D; Pacchetti B; Sodergren MH
    Ther Innov Regul Sci; 2022 Jan; 56(1):8-14. PubMed ID: 34748204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
    Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
    Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relevance of real-world data for the evaluation of neuropathic pain treatments.
    Baron R; Mick G; Serpell M
    Pain Manag; 2022 Oct; 12(7):845-857. PubMed ID: 36106645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.